News Update: Inspire Pharmaceuticals, Inc. Halts Development of Prolacria

From: TradeTheTrend

Added: 16 years ago · 1:14 · 480p

"Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) has put a halt to the development of the dry eye disease drug Prolacria and has ...